Fig. 3From: A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapyRisk score calculated by the signature of D95 and D5, KaplanāMeier survival analysis, and time-dependent ROC curve. a The distribution of risk score and survival status; b KaplanāMeier analysis estimated LRFS of patients according to the median value of risk score; c ROC curve was plotted for 1-, 3-, and 5-year LRFS; d Compared with other dosimetric metrics for predicting local recurrence, the risk model including D5 and D95 had the highest AUC value. LRFS, local recurrence free survival; ROC, receiver operating characteristic curve; AUC, area under curveBack to article page